cutaneous lupus erythematosus
Information
- Disease name
- cutaneous lupus erythematosus
- Disease ID
- DOID:0050169
- Description
- "A lupus erythematosus that causes skin lesions on parts of the body that are exposed to sunlight." [url:https\://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927537/] {comment="sn:IEDB"}
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00317681 | Completed | Phase 2 | Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE) | August 2005 | February 2007 |
| NCT00420173 | Completed | Interdisciplinary Study Group of Lupus Erythematosus (ISGLE) | September 2004 | June 2008 | |
| NCT00470912 | Completed | Phase 3 | Sunscreen RV 2457C in Photoinduced CLE | May 2001 | February 2002 |
| NCT00523588 | Completed | Phase 2 | Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser | March 2007 | January 2010 |
| NCT01146444 | Completed | N/A | Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE) | November 2009 | November 2012 |
| NCT01300208 | Completed | Phase 2 | To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus | October 1, 2010 | March 1, 2013 |
| NCT01776190 | Completed | N/A | Low-dose UVA1 Radiation in Cutaneous Lupus Patients | September 2012 | September 2022 |
| NCT01841619 | Completed | Early Phase 1 | IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus | March 2013 | November 2014 |
| NCT03134222 | Completed | Phase 2 | Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE) | May 24, 2017 | December 18, 2019 |
| NCT03817424 | Completed | Phase 1 | A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis | December 13, 2018 | July 20, 2020 |
| NCT04647708 | Completed | Phase 1 | Study of M5049 in CLE and SLE Participants | December 16, 2020 | December 19, 2023 |
| NCT04781816 | Completed | Phase 2 | Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus | April 1, 2021 | June 26, 2023 |
| NCT01629784 | Completed | N/A | Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus | May 2012 | January 2013 |
| NCT06015737 | Not yet recruiting | Phase 3 | A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus | June 17, 2024 | January 27, 2028 |
| NCT06411106 | Recruiting | N/A | Deep Phenotyping of Cutaneous Lupus Erythematosus | June 2024 | September 2025 |
| NCT01470313 | Terminated | Phase 1 | A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus | November 2011 | November 2013 |
| NCT01498406 | Terminated | Phase 2 | Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus | December 2011 | June 2013 |
| NCT04809623 | Terminated | Phase 1 | Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) | September 1, 2021 | October 18, 2022 |
| NCT03260166 | Unknown status | Phase 2 | Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus | August 31, 2017 | July 1, 2021 |
- Disase is a (Disease Ontology)
- DOID:8857
- Cross Reference ID (Disease Ontology)
- GARD:6225